Trichotillomania

Feb 19, 2020

Global Trichotillomania (TTM) Pipeline Overview 2020: Therapeutic Assessment, Product Profiles, Unmet Needs, Key Companies

Oct 31, 2019

Promentis Pharmaceuticals Announces Positive Results for Phase 2A Study of SXC-2023 Targeting Novel Glutamatergic Mechanism and Completion of Enrollment for Phase 2 Trichotillomania Study

Jan 17, 2019

Promentis Pharmaceuticals Announces Commencement of Phase 2 Studies for SXC-2023 Targeting Novel Glutamatergic Mechanism

Dec 05, 2018

Promentis Pharmaceuticals to present at the 57th annual American College of Neuropsychopharmacology (ACNP) meeting

Nov 16, 2018

Promentis Pharmaceuticals Announces Successful Completion of Phase 1 Studies for SXC-2023 Targeting Novel Glutamatergic Mechanism

Oct 19, 2018

Hair Loss Expert Lucinda Ellery Reveals Why We Need to Talk About Trichotillomania

Aug 09, 2018

HabitAware Receives $300,000 NIH Research Grant to Develop Innovative Awareness Bracelet as a Treatment for Trichotillomania (Hair Pulling Disorder)

Nov 20, 2017

Promentis Pharmaceuticals Commences Phase 1 Study for SXC-2023 Targeting Neuropsychiatric Disorders